HOME
ABOUT DNDi
EDITORIAL:
"NECT is a Success but Many Challenges Still Remain"
CALENDAR
HOW YOU CAN HELP DNDi?
The NECT Story
Nifurtimox-Eflornithine Combination Therapy:
An Improved Treatment for Sleeping Sickness
Gerardo Priotto : Portrait
A Major Step Forward in Improving Treatment Options for HAT
NECT: Next Steps
About Sleeping Sickness
Sleeping Sickness [Human African Trypanosomiasis-HAT]
What DNDi Does to Address Sleeping Sickness
NECT: Contributions to Its Success
HAT Projects Supported by Public and Private Funds
ANECT: Other Studies
TDR investigates NECT in Uganda
HAT Regional Network
The Key Role Played by the HAT Platform
NECT: challenges in The Field
Challenges of Establishing and Monitoring a GCP Trial in Remote Settings
Challenges to Follow HAT Patients Evolution After
Patient’s Story
A Hope for Surviving Sleeping Sickness: Joseph’s Story
Sailing Away
Thank you Angèle
Brief News
Malaria: ASAQ Obtains WHO Prequalification
Chagas Disease: Agreement between Lafepe and DNDi on Safe, Easy-to-Use Treatment for Children
Visceral Leishmaniasis: 11th LEAP meeting takes place in Addis Ababa to Discuss VL Strategy Plan
DNDi Event: Indian Scientists Catalyse Efforts in Research and Development for New Treatments for Neglected Diseases
BBC Documentary on Sleeping Sickness
DND<em>i</em>’s HAT-Related News
Fexinidazole Progresses into Clinical Development
Discovery Programmes for HAT
Contacts DNDi
Credits

Contacts DNDi
For any further information, please contact our communication department:
Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.DNDi.org